对I-III期上状细胞癌的全身疗法:ASCO指南
Van K Morris1, Erin B Kennedy2, Manik A Amin3
1MD Anderson Cancer Center, Houston, TX.
概括
对于I-III阶段的门癌症,建议使用米托米辛-C (MMC) 与胺 (甲或甲) 进行化学辐射. 甲与西斯普拉丁是另一种选择,特别是对于免疫抑制患者.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 门癌症的治疗需要基于证据的指导方针,以获得最佳的患者结果.
- 目前的治疗策略涉及化疗辐射,因此需要明确建议使用化疗剂.
研究的目的:
- 为管理I-III期癌提供基于证据的临床实践指南.
- 建立关于最有效的化学辐射疗法方案的共识.
主要方法:
- 明尼苏达州基于证据的实践中心进行了系统的文献审查.
- 美国临床瘤学会 (ASCO) 专家小组审查了证据并提出了建议.
主要成果:
- 三个随机对照试验和三个非随机研究为指南提供了信息.
- 作为放射敏感剂,建议使用米托米辛-C (MMC) 与甲 (甲[FU]或甲) 相结合.
- 与FU一起的西斯普拉丁是一种替代药物,特别是在由于骨髓抑制减少而受到免疫抑制的患者中.
结论:
- 线粒素-C (MMC) 加上胺是门癌最喜欢的放射敏感化疗.
- 西斯普拉丁加FU是一种可行的替代品,特别是对于免疫抑制患者.
- 对于局部癌,不建议进行常规的诱导或巩固化疗.
更多相关视频
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.7K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
